Prestige Consumer Healthcare Inc. (PBH - Free Report) reported fourth-quarter fiscal 2020 results, wherein both top and bottom lines improved year over year and beat the Zacks Consensus Estimate. This marked the company’s fifth straight beat (on a combined basis).
Quarter in Detail
The company posted adjusted earnings of 82 cents per share, which surpassed the Zacks Consensus Estimate of 74 cents. This marked its ninth consecutive quarter of earnings beat. Quarterly earnings also improved 13.9% year over year.
Total revenues advanced 4.2% to $251.2 million and beat the Zacks Consensus Estimate of $240 million. Organic revenues rose 4.6% (excluding currency effects). Top-line results were backed by robust consumption trends at core brands in the domestic regions and solid international unit performance.
Adjusted gross profit came in at $149.1 million, which grew 7.9% from the prior-year quarter’s figure. Adjusted gross margin expanded 20 basis points (bps) to 59.4%.
Adjusted EBITDA was $85.9 million, up 2.6% year over year. However, adjusted EBITDA margin contracted 50 bps to 34.2%.
Revenues in the North American OTC Healthcare segment were $219.8 million, up 2.3% year over year. The upside is accountable to greater consumption at core brands.
Revenues in the International OTC Healthcare segment totaled $31.4 million, up 20.3% from the year-ago quarter’s figure. The upside can be attributed to solid consumption gains along with favorable distributor order and shipment timings. This was partly negated by currency headwinds to the tune of roughly $1 million.
The company exited the quarter with cash and cash equivalents of $94.8 million, long-term debt (net) of $1,730.3 million and total shareholders’ equity of approximately $1,171 million.
Net cash provided by operating activities in fiscal 2020 was $217.1 million. Adjusted free cash flow for the fiscal amounted to $206.8 million. As of Mar 31, the company’s net debt position was about $1.6 billion. In fiscal 2020, Prestige Consumer lowered debt by $68 million, increased cash and cash equivalents by $67 million and made share buybacks of around $57 million.
The company saw a sharp increase in consumption trends toward late fourth-quarter fiscal 2020, thanks to consumers’ stockpiling driven by coronavirus. However, management expects the trend to reverse in the first quarter of fiscal 2021, as consumers are likely to alter their shopping habits. This reduction is anticipated to be somewhat offset by increased retailer orders. All said, the company expects revenues of roughly $220 million or more in the first quarter of fiscal 2021, with earnings per share expected to be 70 cents or more.
However, the company did not offer any guidance for fiscal 2021 due to the uncertainty surrounding shutdowns and consumer spending led by the COVID-19 crisis. Nonetheless, the company said that it is well placed to navigate through these hurdles, given its robust brand portfolio, disciplined capital allocation and financial flexibility.
This Zacks Rank #3 (Hold) stock has lost 2.3% year to date against the industry’s growth of 1.4%.
Looking for High-Performance Stocks? Here’re a Few
BJ's Wholesale Club (BJ - Free Report) has an expected long-term earnings growth rate of 11% and a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Costco (COST - Free Report) , a Zacks Rank #2 (Buy) stock, has an expected long-term earnings growth rate of 8.6%.
Central Garden Pet (CENT - Free Report) has a long-term earnings growth rate of 5.9% and a Zacks Rank #2.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>